NCT05897801View on ClinicalTrials.gov

Distinguishing Bacterial and Viral Infections by MeMed BV® Test to Limit Gut Colonization by MDRO

CompletedOBSERVATIONAL
Enrollment

230

Participants

Timeline

Start Date

May 29, 2023

Primary Completion Date

December 18, 2023

Study Completion Date

January 31, 2024

Conditions
Viral InfectionBacterial InfectionsMulti-antibiotic ResistanceRespiratory Tract Infections
Interventions
DIAGNOSTIC_TEST

MeMed BV®

One blood sampling of 3ml will be drawn on the first day for the performance of the MeMed BV® test. Two rectal swabs will be taken for determining the MDRO gut colonization. Patient information regarding the specific respiratory tract infection and the treatment regimen being prescribed will be recorded in the eCRF made specifically for this trial.

Trial Locations (3)

12462

Emergency Department of ATTIKON University General Hospital, Attiki

18536

Emergency Department of Tzaneion General Hospital, Attiki

19600

General Hospital of Elefsina 1st Department of Internal Medicine, Elefsina

All Listed Sponsors
lead

Hellenic Institute for the Study of Sepsis

OTHER

NCT05897801 - Distinguishing Bacterial and Viral Infections by MeMed BV® Test to Limit Gut Colonization by MDRO | Biotech Hunter | Biotech Hunter